DBV Technologies expands scientific advisory board
DBV Technologies (DBV) announced the appointment of leading paediatric allergy and allergy specialists Professor N Franklin Adkinson Jr MD and Associate Professor Jonathan M Spergel MD to its Scientific Advisory Board. These SAB appointments are of strategic importance to DBV Technologies, as the Company progresses towards its Phase I clinical trial for peanut allergy in the US.
Professor Adkinson is a Professor of Medicine at Johns Hopkins Asthma and Allergy Centre. His research has contributed to modern day’s understanding of the mechanisms of allergen immunotherapy.
Professor Spergel is an Associate Professor of Pediatrics at the University Of Pennsylvania School Of Medicine. He is also Chief of the Allergy Department and directs the Centre for Pediatric Eosinophilic Disorders at the Children’s Hospital of Philadelphia. He serves as an international expert on the treatment and diagnosis of food allergies.
Other news from the department people
